Panelists discuss potential changes to clinical pathways for Bruton tyrosine kinase (BTK) inhibitor therapies as a result of ...

Real-world cost barriers and insurance denials contribute to early discontinuation of injectable glucagon-like peptide-1 (GLP ...

As clinician shortages grow, hospitals turn to artificial intelligence (AI) and scheduling tools to optimize resources, ...

A panelist discusses the latest advancements presented at ASCO 2025, highlighting talquetamab’s pivotal trial in relapsed/refractory multiple myeloma that demonstrated high response rates and longer ...

B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City, reflects on how the reality of COVID-19 infection proved far more complex than ...

New Jersey Attorney General Matthew Platkin said the question before the court is whether First Choice Women's Resource ...

A prior settlement of $6 billion was rejected because it would have shielded the Sacklers from lawsuits even from parties who ...

Pediatric patients with hidradenitis suppurativa have a significantly increased prevalence of chronic medical and psychiatric ...

New Jersey Attorney General Matthew Platkin said the question before the court is whether First Choice Women's Resource ...

A global surge in rheumatoid arthritis with local hotspots highlights the need for targeted public health interventions.

Panelists discuss how data from MDA 2025 demonstrate that delandistrogene moxeparvovec (gene therapy for DMD) shows ...

Panelists discuss how recent advancements in muscular dystrophy treatment have evolved toward truly disease-modifying ...